Inventor · disambiguated record
Kevin J. Yarema
Also filed as: YAREMA KEVIN · YAREMA KEVIN J
14 granted patents·7 pending applications·266 citations·filing 1995–2023
92Inventor score
Files withUNIV JOHNS HOPKINS9MASSACHUSETTS INST TECHNOLOGY4UNIV CALIFORNIA4YAREMA KEVIN J2AHMED HAFIZ1
Top patents by PatentIndex Score
21 records- 0194US6458937B1Glycoconjugates and methodsUNIV CALIFORNIA·Filed 2000·Granted Oct 1, 2002·79 cites·15 claims
- 0293US7351408B2Glycoconjugates and methodsUNIV CALIFORNIA·Filed 2005·Granted Apr 1, 2008·12 cites·5 claims
- 0392US6936701B2Glycoconjugates and methodsUNIV CALIFORNIA·Filed 2002·Granted Aug 30, 2005·35 cites·18 claims
- 0491US6075134AGlycoconjugates and methodsUNIV CALIFORNIA·Filed 1997·Granted Jun 13, 2000·90 cites·9 claims
- 0577US5879917AProgrammable genotoxic agents and uses thereforMASSACHUSETTS INST TECHNOLOGY·Filed 1995·Granted Mar 9, 1999·35 cites·19 claims
- 0676US8916544B2Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disordersYAREMA KEVIN J·Filed 2008·Granted Dec 23, 2014·2 cites·8 claims
- 0771US2012302514A1Glycoconjugates and methodsBERTOZZI CAROLYN·Filed 2007·Application pending·0 cites
- 0870US9315532B2Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods thereofYAREMA KEVIN J·Filed 2006·Granted Apr 19, 2016·2 cites·15 claims
- 0970US2023414782A1Biomimetic artificial cells: anisotropic supported lipid bilayers on biodegradable micro and nanoparticles for spatially dynamic surface biomolecule presentationUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1069US7169611B2Programmable genotoxic agents and uses thereforMASSACHUSETTS INST TECHNOLOGY·Filed 2002·Granted Jan 30, 2007·1 cites·22 claims
- 1166US2009062236A1Programmable genotoxic agents and uses thereforMASSACHUSETTS INST TECHNOLOGY·Filed 2007·Application pending·0 cites
- 1265US9067960B2Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disordersUNIV JOHNS HOPKINS·Filed 2014·Granted Jun 30, 2015·0 cites·17 claims
- 1359US11827663B2Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathwayUNIV JOHNS HOPKINS·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 1457US10227369B2Short-chain fatty acid hexosamine analogs and their use in tissue engineering applicationsUNIV JOHNS HOPKINS·Filed 2014·Granted Mar 12, 2019·0 cites·12 claims
- 1551US2024279328A1Methods to glycoengineer proteinsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1651US2016151400A1Hybrid scfa-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disordersUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 1751US2018256745A1Biomimetic artificial cells: anisotropic supported lipid bilayers on biodegradable micro and nanoparticles for spatially dynamic surface biomolecule presentationUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 1848US6500669B1Programmable genotoxic agents and uses thereforMASSACHUSETTS INST TECHNOLOGY·Filed 1998·Granted Dec 31, 2002·10 cites·36 claims
- 1945US10899784B2Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathwayUNIV JOHNS HOPKINS·Filed 2015·Granted Jan 26, 2021·0 cites·7 claims
- 2040US11015215B2Use of high flux SCFA-derivatized monosaccharides in recombinant glycoprotein productionUNIV JOHNS HOPKINS·Filed 2015·Granted May 25, 2021·0 cites·8 claims
- 2135US2018050055A1Exploiting nutrient deprivation for modulation of glycosylation - research diagnostic, therapeutic, and biotechnology applicationsAHMED HAFIZ·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin J. Yarema files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →